The Indian benchmark indices ended on a higher note on Tuesday amid strong global cues. Nifty ended 121.65 pts or (0.53%) higher at 23,207.60 whereas Sensex ended 169.62 pts or (0.22%) higher at 76,499.63 level.
The Indian stock markets started the trading session on a strong note, entering the green zone at the opening bell. The benchmark index Sensex opened at 76,701.68, registering a gain of 371.67 points, marking a positive change of 0.49% from the previous closing level.
Similarly, the broader market index Nifty 50 surpassed the 23,200 mark, opening at 23,218.90, with an impressive rise of 132.95 points, reflecting a 0.58% increase.
The stock market is poised for a positive opening today, driven by gains in the GIFT Nifty index during early trading hours. As of 8:15 AM, GIFT Nifty futures were trading at 23,268, with a marginal decline of 0.04% compared to the previous session's close.
On January 13, the Indian equity markets faced a significant downturn, marking the fourth consecutive session of losses. The benchmark indices saw a sharp decline due to widespread selling across various sectors, including banking, IT, and metals. The BSE Sensex plummeted by 1,048.90 points, equivalent to a 1.36% drop, closing at 76,330.01. Meanwhile, the NSE Nifty also experienced a substantial fall, shedding 345.55 points or 1.47% to settle at 23,085.95.
LIVE Feed
Jan 14, 2025, 3:38 pm IST
Nifty Outlook By Anand James, Chief Market Strategist, Geojit Financial Services
The 23000 region has prompted the bulls to regroup. However, while this was anticipated, there is little else to suggest that this is anything more than a dead cat bounce. Alternatively, a direct rise above 23370 could spark a 23640 move. For the day, despite the threat of “sell on rallies” mode ever-present, we may play for upswings as long as above 23176.
Jan 14, 2025, 3:03 pm IST
Le Travenues Technology | Emerging dark horse in the OTA market
Swapnil Potdukhe of JM Financial Institutional Securities said, “ixigo’s journey to becoming an online travel agency (OTA) has been rather tumultuous. It started as a meta search website, then pivoted to enabling trip planning and advisory services and later took the unconventional route of building a utility services platform for India’s biggest travel use case, trains, before turning into an OTA. Although ixigo was a late entrant, it is now the second largest OTA basis total gross transaction value (GTV). Segment-wise, it is a market leader in train-ticketing while fast consolidating its position in flight and bus ticketing. We initiate on ixigo with a BUY rating and a Mar'26 TP of INR 180, valuing the business at 65x Mar’27 EPS – broadly in line with growth-adjusted multiples for our internet coverage. ixigo follows a multi-app, multi-brand approach. Its customers are well dispersed across lower-tier towns and cities, with ~94% of its transactions booked having either origin or destination as non-tier-1 cities. The company stands out amongst travel-tech peers as it generates the highest customer engagement and usage (all ixigo apps combined), despite being relatively frugal when spending on branding and marketing. This is because a large chunk of traffic on its platforms comes to avail a wide range of utility services that the company provides for free. Gradually, some of this traffic organically starts utilising the company’s travel booking services, thus ensuring low cost of acquisition. Unlike most OTAs that focus on better pricing or discounts, ixigo focuses on differentiation basis superior customer experience. The company achieves this basis out-of-the-box utility products and services and value-added services (for a small fraction of the ticket value) that enable customers to modify or cancel their bookings without having to worry about cancellation cost. The company also strives to maintain high service quality standards through instant customer-issue resolutions (led by AI-driven chatbots) and swift refunds (sometimes without waiting for travel service providers to initiate the process).”
Jan 14, 2025, 2:34 pm IST
Carysil: Maintained guidance; reiterate BUY
“We visited Carysil Ltd's plant at Bhavnagar wherein we interacted with the CMD, CFO and plant heads regarding the plant and company’s operations, various product segments, company’s subsidiaries, and growth initiatives taken. Based on our discussion, we continue to value the company at P/E(x) of 25x on FY27E EPS, arriving at a target price of Rs1,035. At CMP, the stock trades at P/E(x) of 20.0x/16.1x on FY26E/FY27E EPS of Rs33.4/41.4 respectively. Hence, we reaffirm our BUY rating on the stock,” said Yes Securities in a note.
Amey Chalke of JM Financial Institutional Securities said, “In a seasonally weak quarter, we expect hospital companies to lead the healthcare space with 16%/20%YoY Revenue/EBITDA growth followed by diagnostics with 14%/19% Revenue/EBITDA growth and Pharma with 9%/11% Revenue/EBITDA growth. In a seasonally weak quarter, KIMS and JLHL to outperform hospital peers while VIJAYA to lead in diagnostic space. Hospitals’ revenue growth is promising led by bed addition, improving occupancy as facilities mature and better case/payor mix. Diagnostic companies would see improving volume traction on YoY basis led by increasing proportion of bundled tests and marketing efforts. In pharma, this quarter would see benefits of a flu season in USA, blockbuster launches and benign raw material cost. We expect healthy EBITDA growth in BIOS, IPCA, LPC, JBCP but slightly weaker YoY performance from CIPLA and ARBP. Among diagnostic companies, we prefer METROHL due to the company’s B2C focus, growing wellness share and attractive valuations vs. peers. In Hospitals, MEDANTA given its strong emphasis on clinical excellence, high-quality assets, and new developments remains our top pick. Pharma space is seeing the peak of the generic cycle. Product concentration risk is at the highest. On FY27 normalised earnings and attractive valuations, we like DRRD given its initiatives to tide over the gRevlimid vacuum while we prefer PIRPHARM in CDMO space.”
Jan 14, 2025, 1:18 pm IST
Flash Update: JSW Energy | KSK Mahanadi acquisition
“JSW Energy has received LOI for 3600MW KSK Mahanadi for a consideration of INR 160bn. It generated an EBITDA of INR 24bn in FY24 from four operational units. We expect additional capex of INR 98 bn for completing rest of the units. As per media news, JSW Energy paid around INR 160 bn. So, as per our initial estimates, the transaction is valued at 5.5-6.5x EV/EBITDA on full capacity which can be commissioned in 3-4 years,” commented Sudhanshu Bansal of JM Financial Institutional Securities.
Jan 14, 2025, 12:51 pm IST
Result Update: Just Dial | Collection growth moderates
Swapnil Potdukhe of JM Financial Institutional Securities said, “Just Dial reported muted revenue growth of 8.4% YoY in 3QFY25, a miss on JMFe by c.3%. As a result, despite broadly in-line margin expansion of 740bps YoY, EBITDA of INR 866mn (+43% YoY) missed our estimate by 3%. While sequential paid campaign additions stood at just 2.6k versus JMFe of 6.2k, average realisation of INR 19.2k was below JMFe of INR 19.6k. Cash collections, a lead indicator for revenue too was weak at 3.4% YoY (growth decelerating from ~8% in 2Q). Traffic trends however remained robust at 15% YoY, despite only just modest increase in A&P. However, there was no update on the company’s earlier announced plans to distribute full year profits/cash generated to shareholders. Slowing topline trends leads to a cut in our target PER multiple (ex-other income) from 20x to 18x. We roll-forward to Mar’26 for a revised TP of INR 1,220. Ex-cash and other income, stock trades at 13x/10x FY26/27 PER (as cash & investments account for ~60% of market cap).”
Jan 14, 2025, 10:22 am IST
Top 5 Gainers And Losers Today
Stock Market Live Updates
Jan 14, 2025, 9:41 am IST
Stock Market Live Updates: Indian Rupee Hits Fresh Low Against the Dollar
The Indian rupee touched a new low of 86.40 against the US dollar during Monday’s trading session, weighed down by stronger-than-expected US non-farm payroll data. The currency opened at 86.49, registering a 0.3% increase compared to its previous close.
Jan 14, 2025, 8:55 am IST
Stock Market Live Updates: Asia Market Performance
The markets in Asia are undergoing mixed performance on Tuesday following a volatile session on Wall Street. The Shanghai Composite gained 61.75 points or 1.95% currently trading at 3,222.50, while Japan's Nikkei 225 declined by 1.84%.. The Hang Seng Index (HSI) in Hong Kong rose 276.60 points or 1.47% to trade at 19,150.74, and the Shenzhen Component is up 2.92%. South Korea's Kospi edged up by 1.87 points or 0.08% to reach 2,491.43. While Australia’s ASX 200 is trading 0.33% higher.
Jan 14, 2025, 8:50 am IST
Stock Market Live Updates: US Market Performance
The US markets saw mixed movements in the latest trading session. The Dow Jones Industrial Average climbed by 358.67 points, or 0.86%, closing at 42,297.12. The S&P 500 recorded a modest gain of 9.18 points, or 0.16%, ending at 5,836.22. Meanwhile, the Nasdaq Composite registered a decline, dropping 73.53 points, or 0.38%, to finish at 19,088.10.
Jan 14, 2025, 8:41 am IST
Stock Market Live Updates: Markets at the Previous Close
On Monday, the stock markets witnessed a sharp sell-off, with both the Sensex and Nifty slipping more than 1% as equities extended losses for the fourth consecutive session.
At the close, the Sensex was down 1,048.90 points or 1.36%, settling at 76,330.01. The Nifty fell by 345.55 points or 1.47% to end at 23,085.95. All sectoral indices closed in the red, indicating a broad-based sell-off across industries.
Jan 14, 2025, 8:41 am IST
Stock Market Live Updates Welcome to the Stock Market Live Blog
Good morning, and welcome right here in our live blog! As Sensex and Nifty set the pace today, we’re here to guide you through every market move.stay with us for real-time updates, insights from the equity market
Click it and Unblock the Notifications
Sign in with Google